PENNISI, MARIA STELLA
 Distribuzione geografica
Continente #
NA - Nord America 885
EU - Europa 500
AS - Asia 309
SA - Sud America 127
AF - Africa 115
OC - Oceania 1
Totale 1.937
Nazione #
US - Stati Uniti d'America 876
IT - Italia 249
SG - Singapore 156
BR - Brasile 119
IE - Irlanda 95
CN - Cina 86
CI - Costa d'Avorio 74
DE - Germania 49
SN - Senegal 34
VN - Vietnam 28
RU - Federazione Russa 25
BE - Belgio 12
GB - Regno Unito 11
FI - Finlandia 9
CA - Canada 8
CZ - Repubblica Ceca 8
SE - Svezia 8
TR - Turchia 7
IN - India 6
UA - Ucraina 6
UZ - Uzbekistan 6
CH - Svizzera 4
FR - Francia 4
JP - Giappone 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
EC - Ecuador 3
IQ - Iraq 3
NO - Norvegia 3
BD - Bangladesh 2
ES - Italia 2
GR - Grecia 2
HK - Hong Kong 2
MA - Marocco 2
NG - Nigeria 2
NL - Olanda 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LU - Lussemburgo 1
MX - Messico 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 1.937
Città #
Santa Clara 204
Chandler 194
Chicago 100
Dublin 95
Singapore 90
Abidjan 74
Catania 60
Civitanova Marche 34
Dakar 34
Ashburn 32
Boardman 31
Cambridge 27
Lawrence 25
Andover 24
Grafing 23
Dong Ket 22
Wilmington 17
Des Moines 14
Munich 14
Brussels 12
Council Bluffs 12
Beijing 11
Palermo 11
Nanjing 10
Los Angeles 9
Santa Venerina 9
Brno 8
Helsinki 8
Bari 7
Belo Horizonte 6
Hanoi 6
Milan 6
Pune 6
São Paulo 6
Aci Catena 5
Seattle 5
Toronto 5
Bremen 4
Edinburgh 4
Falls Church 4
Giardini-Naxos 4
Houston 4
Jiaxing 4
Saint Petersburg 4
Tokyo 4
Tremestieri Etneo 4
Catanzaro 3
Fantina 3
Frankfurt am Main 3
Hanover 3
Jinan 3
Manaus 3
Messina 3
Oslo 3
San Giovanni la Punta 3
Woodbridge 3
Abuja 2
Belém 2
Campo Grande 2
Casablanca 2
Comiso 2
Cáceres 2
Dubai 2
Fairfield 2
Guarulhos 2
Istanbul 2
Jacksonville 2
Joinville 2
London 2
Madrid 2
Marília 2
Mascali 2
Moscow 2
Nanchang 2
Newham 2
Ottawa 2
Quito 2
Rio de Janeiro 2
Sant'Agata di Militello 2
Siracusa 2
Tashkent 2
Toledo 2
Zhengzhou 2
Acapulco de Juárez 1
Aci Sant'Antonio 1
Ahmetli 1
Alagoinhas 1
Amman 1
Ann Arbor 1
Aparecida 1
Araras 1
Aryanah 1
Asunción 1
Athens 1
Baghdad 1
Baku 1
Bangkok 1
Barcellona Pozzo di Gotto 1
Barnaul 1
Barão de Cocais 1
Totale 1.393
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 149
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 109
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 90
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 81
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 80
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 80
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 78
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 77
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 77
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 77
New insights in thyroid cancer and p53 family proteins 76
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 75
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 74
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 69
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 69
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 68
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 67
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 67
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 66
Opportunities and challenges of liquid biopsy in thyroid cancer 61
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 59
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 58
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 58
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 57
The Role of New Technologies in Myeloproliferative Neoplasms 55
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 54
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 43
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 34
Totale 2.008
Categoria #
all - tutte 8.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 0 0 1 5 10 21
2020/2021113 10 0 3 10 23 5 2 2 26 2 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025767 13 154 38 87 187 132 97 30 29 0 0 0
Totale 2.008